Number of treatment rooms expected by 2030 drops from 1,200 to 900, accounting for financial, regulatory considerations
January 2, 2018 — MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200 to 900. The company said this still represents a 12 percent annual growth from 2017 to 2030, and the need to open an average of more than 50 proton therapy treatment rooms every year from 2018 to 2030.
However, with the growing clinical evidence regarding the efficacy of particle therapy that will progressively be used to treat a broader number of indications, there is room for a further acceleration of the market especially if the industry brings the cost of equipment down, according to the report.
MEDraysintell is delaying the release of the fifth edition of its Proton Therapy World Market Report and Directory to mid-January 2018, when all the latest information will be collected for the last month of 2017. The new edition will provide a comprehensive review of the world market dynamics, with an analysis of both past evolutions and future trends to the year 2030, including a detailed profile of all promoters, manufacturers or developers of proton and carbon therapy equipment.
For more information :
https://www.itnonline.com/content/medraysintell-downgrades-proton-therapy-market-projection-2030
🆔 @partohair
January 2, 2018 — MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200 to 900. The company said this still represents a 12 percent annual growth from 2017 to 2030, and the need to open an average of more than 50 proton therapy treatment rooms every year from 2018 to 2030.
However, with the growing clinical evidence regarding the efficacy of particle therapy that will progressively be used to treat a broader number of indications, there is room for a further acceleration of the market especially if the industry brings the cost of equipment down, according to the report.
MEDraysintell is delaying the release of the fifth edition of its Proton Therapy World Market Report and Directory to mid-January 2018, when all the latest information will be collected for the last month of 2017. The new edition will provide a comprehensive review of the world market dynamics, with an analysis of both past evolutions and future trends to the year 2030, including a detailed profile of all promoters, manufacturers or developers of proton and carbon therapy equipment.
For more information :
https://www.itnonline.com/content/medraysintell-downgrades-proton-therapy-market-projection-2030
🆔 @partohair
Imaging Technology News
MEDraysintell Downgrades Proton Therapy Market Projection for 2030
MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200 to 900. The company said this still represents a 12 percent annual growth from 2017 to 2030, and the need to open an average of more than…
مهلت ثبت نام:20 بهمن ماه 1396
هزینه ثبت نام:اساتید و محققین 150 و دانشجویان 75 هزار تومان
اقامت تحت شرایط خاصی امکان پذیر است.
🆔 @partohair
هزینه ثبت نام:اساتید و محققین 150 و دانشجویان 75 هزار تومان
اقامت تحت شرایط خاصی امکان پذیر است.
🆔 @partohair
Study Compares Radiosurgery and Whole-Brain Radiation in Lung Cancer Patients With Multiple Brain Metastases
More information 👇
🆔 @partohair
More information 👇
🆔 @partohair
Results indicate the brain receives less dose with radiosurgery, even when treating 10 or more lesions
January 3, 2018 — Although targeted therapies have produced dramatic advances in the ability to control some types of advanced lung cancer, growth of the disease in the brain remains a major problem. Radiation is often used to treat deposits in the brain, but the best technique to deliver radiation can be controversial. Whole-brain radiation therapy, as its name suggest, treats the entire brain but can be associated with notable cognitive side effects. Another strategy, radiosurgery, directs highly-focused radiation only to the sites of metastasis, largely sparing the normal brain.
Whole-brain radiation delivers a radiation dose of approximately 30 Gy to the entire brain. A technique known as “hippocampal-sparing” or “hippocampal-avoidance” radiation delivers the same dose of radiation to the bulk of the brain, but only about 10 Gy to the hippocampus. The maximum radiation dose experienced with radiosurgery, even with many metastases, was 1.2 Gy in the hippocampus and 0.8 Gy across the whole brain.
“The very low doses of radiation to the normal brain observed with radiosurgery compared to whole-brain radiation has the potential to dramatically alter the risk of cognitive side effects,” said Rusthoven. “As the field of oncology evolves, we have to evolve with it. Patients with cancer who are eligible for targeted therapies are living longer than ever before, making treatment strategies that support long term quality of life even more important.”
For more information :
https://www.itnonline.com/content/study-compares-radiosurgery-and-whole-brain-radiation-lung-cancer-patients-multiple-brain
🆔 @partohair
January 3, 2018 — Although targeted therapies have produced dramatic advances in the ability to control some types of advanced lung cancer, growth of the disease in the brain remains a major problem. Radiation is often used to treat deposits in the brain, but the best technique to deliver radiation can be controversial. Whole-brain radiation therapy, as its name suggest, treats the entire brain but can be associated with notable cognitive side effects. Another strategy, radiosurgery, directs highly-focused radiation only to the sites of metastasis, largely sparing the normal brain.
Whole-brain radiation delivers a radiation dose of approximately 30 Gy to the entire brain. A technique known as “hippocampal-sparing” or “hippocampal-avoidance” radiation delivers the same dose of radiation to the bulk of the brain, but only about 10 Gy to the hippocampus. The maximum radiation dose experienced with radiosurgery, even with many metastases, was 1.2 Gy in the hippocampus and 0.8 Gy across the whole brain.
“The very low doses of radiation to the normal brain observed with radiosurgery compared to whole-brain radiation has the potential to dramatically alter the risk of cognitive side effects,” said Rusthoven. “As the field of oncology evolves, we have to evolve with it. Patients with cancer who are eligible for targeted therapies are living longer than ever before, making treatment strategies that support long term quality of life even more important.”
For more information :
https://www.itnonline.com/content/study-compares-radiosurgery-and-whole-brain-radiation-lung-cancer-patients-multiple-brain
🆔 @partohair
Imaging Technology News
Study Compares Radiosurgery and Whole-Brain Radiation in Lung Cancer Patients With Multiple Brain Metastases
Although targeted therapies have produced dramatic advances in the ability to control some types of advanced lung cancer, growth of the disease in the brain remains a major problem. Radiation is often used to treat deposits in the brain, but the best technique…
California US Oncology Network Centers Adopt Xoft Electronic Brachytherapy System for Early-Stage Non-Melanoma Skin Cancer
More information 👇
🆔 @partohair
More information 👇
🆔 @partohair